نتایج جستجو برای: genomic targeted therapy

تعداد نتایج: 883589  

Journal: :Neuro-oncology 2015
Michael D Prados Sara A Byron Nhan L Tran Joanna J Phillips Annette M Molinaro Keith L Ligon Patrick Y Wen John G Kuhn Ingo K Mellinghoff John F de Groot Howard Colman Timothy F Cloughesy Susan M Chang Timothy C Ryken Waibhav D Tembe Jeffrey A Kiefer Michael E Berens David W Craig John D Carpten Jeffrey M Trent

Integrated sequencing strategies have provided a broader understanding of the genomic landscape and molecular classifications of multiple cancer types and have identified various therapeutic opportunities across cancer subsets. Despite pivotal advances in the characterization of genomic alterations in glioblastoma, targeted agents have shown minimal efficacy in clinical trials to date, and pati...

2012
Jian Yang Lunan Yan Wentao Wang

Hepatocellular carcinoma (HCC) is the fifth most common cancer in the world. Surgery offers the only hope for cure. However, the potentially curable method is only possible for a small proportion of those afflicted, for the rest, palliative treatment is indicated. Despite all the treatment options when used as monotherapy, patients with HCC have a poor long term prognosis. In this setting, mult...

Journal: :Der Gynäkologe 2009

Journal: :Pediatric blood & cancer 2016
Michael V Ortiz Rachel Kobos Michael Walsh Emily K Slotkin Stephen Roberts Michael F Berger Meera Hameed David Solit Marc Ladanyi Neerav Shukla Alex Kentsis

BACKGROUND Pediatric oncologists have begun to leverage tumor genetic profiling to match patients with targeted therapies. At the Memorial Sloan Kettering Cancer Center (MSKCC), we developed the Pediatric Molecular Tumor Board (PMTB) to track, integrate, and interpret clinical genomic profiling and potential targeted therapeutic recommendations. PROCEDURE This retrospective case series includ...

2017
Min Lu Amelia S Zessin Wayne Glover David S Hsu

BACKGROUND Standard of care treatment for colorectal cancer liver metastasis consists of a cytotoxic chemotherapy in combination with a targeted agent. Clinical trials have guided the use of these combinatory therapies, but it remains unclear what the optimal combinations of cytotoxic chemotherapy with a targeted agent are. METHODS Using a genomic based approach, gene expression profiling was...

Journal: :basic and clinical cancer research 0
r sheikhnejad molecular and cancer biology, tofigh darau, research and drug engineering company, tehran, iran m hamedani molecular and cancer biology, tofigh darau, research and drug engineering company, tehran, iran elahe faramarzi molecular and cancer biology, tofigh darau, research and drug engineering company, tehran, iran h jabari bronchoscopy center, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran a kiani pathology department, masih daneshvari hospital, shahid beheshti university of medical sciences, tehran, iran farzaneh khani molecular and cancer biology, tofigh darau, research and drug engineering company, tehran, iran

background : lung cancer is still the leading cause of cancer- related deaths and most of themâ  are normally diagnosed in late stages, so there is an urgent need to establish reliable tools for the identification at early stages of the disease. in this study, we use an eleven gene signature test to examine lung biopsy specimens for diagnostic, prognostic & therapeutic purposes. methods : bronc...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید